Блог им. Shark_Traders |Аналитика NYSE на 16 октября

Спайдер незначительно повышается перед открытием торгов на NYSE.  
  • Европейские индексы на отрицательной  территории.  
 

SPY (внутридневной график)  снижение   премаркете. Поддержка 170.00, сопротивление 171.40   
 
 
Премаркет NYSE/NASDAQ:
Повышаютсянапремаркете:
  • In reaction to strong earnings/guidance: MLNK +11%, MAT +4.5%, KEY +1.6%, ABT +1.5%, PNC +1.2%, YHOO +1.1%, (also Enters into Amendment to Share Repurchase and Preference Sale Agreement with Alibaba), IBM +0.7%, CSX +0.5%,.
  • M&A news: MNTG +0.8% (MTR Gaming Responds to Unsolicited Non-Binding Proposal from Jacobs Entertainment (JEC); plans to evaluate the proposal).
  • Select financial related names showing strength: IRE +4.7%, ING +2.2%, BBVA +1.6%, BCS +1.4%, C +1.4% (following postive Barron's mention),  DB +1.3%, JPM +0.6%.
  • Solar stocks trading higher: RSOL +3%, TSL +2.5%, DQ +2%, YGE +1.9%, SOL +1.9%, SPWR +1.3%, FSLR +1% ( to Build 250MW Power Plant in California for NextEra Energy Resources),.


( Читать дальше )

Блог им. Shark_Traders |Аналитика NYSE на 30 сентября

Аналитика NYSE на 30 сентября
 
Спайдер снижается перед открытием торгов на NYSE.  
  • Европейские индексы на отрицательной территории.
 
SPY (внутридневной график)  снижение на   премаркете. Поддержка 167.50, сопротивление 168.00
 
 
Премаркет NYSE/NASDAQ:
Gapping up:
  • In reaction to strong earnings/guidance: CRRS +7.8%.
  • M&A news: ACTV +27.4% (Active Network to be acquired by Vista Equity Partners; stockholders to receive $14.50 per share), CHRM (Charm Communications announces receipt of 'going private' proposal priced at $4.70 per ADS).
  • Other news: DCTH +30% (received Orphan Drug Designation for Treatment of patients with hepatocellular carcinoma ), ORB +8% (Orbital Sciences' unmanned cargo ship has reached the Intl space station, according to reports), QCOR +4.6% (still checking), NSPH +4.3% ( Study Demonstrates Significant Clinical and Economic Impact of Nanosphere's Verigene Blood Culture Test; Average per Patient Hospital Cost Savings of $60,000 and 22 Day Reduction in Length of Stay Observed), ZAZA +4% ( Announces Second Transaction with JV Partner to Acquire Additional Production and Further Develop Its Eaglebine/Eagle Ford East Assets), RMTI +3.1% (continued strength), CYTR +1.8% (reports new Aldoxorubicin data that demonstrates significant advantages over doxorubicin; provides additional updates on other Phase 2 studies ), HALO +1.8% (presents PEGPH20 Phase 1b clinical trial data that suggest a potential clinical benefit of using PEGPH20 with gemcitabine in patients with high levels of tumor associated hyaluronan), HNR +1.4% (announces exclusive negotiations to sell interest in Gabon for $137 mln in cash), AZN +0.6% (NKTR reported that partner AZN announced European Medicines Agency acceptance of Marketing Authorisation Application for Naloxegol), PMT +0.6% ( Hayman Capital Management discloses 5.1% passive stake in 13G filing out Friday after the close).


( Читать дальше )

Блог им. Shark_Traders |Аналитика NYSE на 11 сентября

Аналитика NYSE на 11 сентября
 
Спайдер остается без изменений перед открытием торгов на NYSE.  
  • Европейские индексы на положительной территории.
 
SPY (внутридневной график)  боковое  движение   на   премаркете. Сопротивление: 169.00           Поддержка: 168.50
 
Премаркет NYSE/NASDAQ:
Gapping up:
  • In reaction to strong earnings/guidance: LCI +4.1%, UNIS +1.6%.
  • Other news: HNR +37.3% (announces exclusive negotiations to sell co including Venezuela; spin-off of remaining assets for total consideration of ~ $373 mln), VTUS +10.5% (announces positive results from clinical dermal safety and pharmacokinetic studies of Diltiazem), SNX +8.9% (Synnex and IBM announces strategic partnership in customer care market; SYNNEX will acquire IBM's worldwide customer care business process outsourcing services business for $505 mln), PSTI +5.9% (Pluristem Therapeutics receives US patent for treatment of peripheral artery disease), SHLD +4.4% ( NYPost discusses recent strength in shares of SHLD on speculation of undervalued real estate assets), THRX +3.6% (confirms FDA Advisory Committee recommends approval of umeclidinium/vilanterol for the treatment of COPD), BID +3% (announces review of capital allocation and financial policies), XOOM +2.3% (prices 4,403,270 shares of common stock in follow on offering at $30.50 per share, shares sold by co and selling share holders), KIOR +2.1% (cont strength following yesterday's gains), YGE +1.9% (to supply 28 mw of pv modules for the state grid corporation of China), NWSA +1.2% (Southeastern Asset Management disclosed 11.9% passive stake in 13G filing out last night after the close), RCL +0.9% (easing Syria/Med Sea tensions).


( Читать дальше )

....все тэги
UPDONW
Новый дизайн